We previously reported that genetically obese mice exhibit innate airway 3 hyperresponsiveness (AHR) and enhanced ozone (O 3 )-induced pulmonary inflammation. Such 4 genetic deficiencies in mice are rare in humans, and may not be representative of human obesity. 5
INTRODUCTION 1 approximately 0.11 ml, were introduced from end-expiratory volume using the flexiVent. 1
Airway opening pressure was measured after each increment in volume was held for 1 s. 2
Measurements of baseline pulmonary mechanics and responses to i.v. methacholine were 3 then obtained using the forced oscillation technique (flexiVent; SCIREQ Inc.; Montreal, Quebec, 4 Canada), as described previously (29; 37; 48; 54) . Mice were given a brief inflation to 3 times 5 V T to standardize volume history. One minute later, phosphate-buffered saline (PBS) was 6 administered (1 µl/g), and total pulmonary resistance (R L ) was measured using a 2.5 Hz 7 sinusoidal forcing function every eighth breath for the next 1-2 min, until R L peaked. Because 8 both the airways and the lung tissues can contribute to R L , we also measured airway resistance 9 (R aw ) and the coefficients of lung tissue damping (G) and lung tissue elastance (H) in these mice. 10
To do so, we used an 8 s optimized pseudorandom forcing function containing frequencies 11 ranging from 0.25 to 19.63 Hz to obtain measurements of total lung impedance (Z L ). A 12 parameter estimation model (19) was used to partition Z L into components representing R aw , G, 13 and H. Use of this model in mice has been verified by ourselves and others (20; 46; 48; 64) . 14 Once measurements of the response to PBS were complete, the mouse was given another 15 inflation to 3 times V T , and the procedure was repeated using doses of methacholine dissolved in 16 PBS increasing in approximate half-log intervals from 0.03 to 1.0 mg/ml at a dose of 1 µl/g. In 17
some of the mice, we were unable to cannulate their tail veins for the delivery of methacholine. 18
However, baseline pulmonary mechanics and quasi-static pressure volume curves were measured 19 in all animals. 20 21 Blood Collection. Blood was collected from the heart via cardiac puncture after euthanasia with 22 pentobarbital sodium. The total number of blood leukocytes was determined as described2 (MIP-2), sTNFR1, and sTNFR2 were determined with either ELISAs or DuoSet ELISA 1 development kits (R&D Systems Inc.; Minneapolis, MN), according to the manufacturer's 2 instructions. 3 4 Statistical Analysis. Comparisons of pulmonary mechanics, quasi-static elastance, and serum 5 markers of inflammation were made by unpaired Student t-tests. Comparisons of BALF 6 parameters were assessed using factorial ANOVA, using diet and exposure as the main effects. 7
Fisher's least significant difference (LSD) test was used as a follow-up to determine the 8 significance of differences between individual groups. STATISTICA software (StatSoft ® ; Tulsa, 9 OK) was used to perform all statistical analyses. The results are expressed as the mean±SEM, 10 except where noted. A p value less than 0.05 was considered significant. 11
RESULTS 1 2
Effect of DIO on body mass. Mice fed a diet consisting of 60% fat from weaning weighed 3 significantly more than mice fed a diet consisting of 10% fat (Table 1) . At 20-22 weeks of age, 4 mice fed a 60% fat diet weighed approximately 37% more than mice fed a 10% fat diet while 5 mice 30-38 weeks of age weighed approximately 39% more than mice fed a 10% fat diet. 6 7 Effect of DIO on pulmonary mechanics and airway responsiveness. At 20-22 weeks of age, 8
there was no effect of diet on baseline airway and parenchymal oscillation mechanics (R L , R aw , 9 G, and H) ( Table 1 ). In mice that were at least 30 weeks of age and older, baseline R L , R aw , and 10 H were greater in mice reared on a 60 versus a 10% fat diet. 11
In 20-22 week old mice, there was no difference in airway responsiveness to 12 methacholine between mice fed 10 versus 60% fat diets ( Figure 1A ). In contrast, in mice at least 13 30 weeks of age and older, there was a significant effect of diet on airway responsiveness to 14 methacholine: for all concentrations of methacholine, with the exception of 1 mg/ml, mice fed a 15 60% fat diet had significantly greater R L responses ( Figure 1B ) than mice fed a 10% fat diet. To 16 determine the locus (airways versus parenchyma) of this diet-induced change in responsiveness, 17 we also measured methacholine-induced changes in R aw , G, and H (Figure 2 ). Methacholine 18 administration increased R aw in both diet groups. However, the increases in R aw were 19 significantly greater in the mice fed a 60 versus 10% fat diet (Figure 2A ). There were no 20 methacholine-induced changes in G or H in mice fed either diet ( Figures 2B and 2C ).
Effect of DIO on quasi-static pressure-volume (PV) curves. We have previously reported that 1 the quasi-static lung elastance (E) of genetically obese mice is increased when compared to lean, 2 wildtype controls (29; 37). To determine whether dietary obesity impacted E, we generated 3 quasi-static PV curves in open-chested, wildtype (C57BL/6) mice fed a diet consisting of either 4 10 or 60 % fat ( Figure 3A and 3B) . There was no effect of diet on quasi-static lung elastance in 5 mice 20-22 weeks of age or in mice 30 weeks of age and older (Table 1) . 6 7 Effect of DIO on O 3 -induced lung hyperpermeability and inflammation. Following 8 exposure to room air, there was no effect of DIO on any of the outcome indicators analyzed in 9 the BALF in mice 30 weeks of age and older (Figures 4 and 5) . O 3 causes disruption of the lung 10 epithelial barrier leading to increased permeability that is routinely assessed by determining the 11 levels of BALF protein (2; 3; 65). To determine the effect of DIO on O 3 -induced lung 12 hyperpermeability, we examined the levels of BALF protein 4 h following the cessation of O 3 13 exposure. O 3 exposure increased the levels of BALF protein ( Figure 4A ). However, the levels 14 of BALF protein were increased to a greater extent in mice with DIO. We also examined the 15 effect of DIO on O 3 -induced pulmonary inflammation by determining the number of BALF 16 neutrophils, epithelial cells, and macrophages following the cessation of O 3 exposure (Figure 4 17 B, C, and D). In both dietary groups, O 3 exposure increased the number of BALF neutrophils 18 and epithelial cells, but decreased the number of BALF macrophages. However, there was no 19 effect of diet on any of these outcome indicators. 20 1 fed mice. Because we have observed greater increases in chemokines in obese ob/ob, db/db, and 2
Cpe fat versus lean, wildtype mice exposed to O 3 (29; 37; 54), we also examined the effect of 3 dietary obesity on BALF eotaxin, KC, MIP-2, and IP-10 ( Figure 5 ). Four hours following O 3 4 exposure, the levels of BALF eotaxin, KC, MIP-2, and IP-10 were significantly greater in mice 5 fed a 60 versus 10% fat diet. Finally, because IL-6 can influence the levels of sTNFR1 and 6 sTNFR2 (28; 63) and because IL-6 expression is increased in mice with DIO, we determined the 7 BALF levels of these sTNFRs in mice fed diets consisting of either 10 or 60% fat. Following 8 exposure to O 3 , the levels of BALF sTNFR1 and sTNFR2 were greater in mice fed a 60 versus 9 10% fat diet. 10
In contrast to the mice 30 weeks of age and older, there was no effect of diet on O 3 -11 induced changes in BALF protein, cells, cytokines or chemokines in mice 20-22 weeks of age 12 (data not shown). 13
14
Effect of DIO on systemic markers of inflammation. We and others have previously reported 15 that markers of systemic inflammation, including certain pro-inflammatory cytokines and 16 chemokines, soluble cytokine receptors, and total blood leukocytes, are elevated in the serum of 17 genetically obese mice (22; 29; 30; 37) . To determine whether DIO also leads to the 18 development of systemic inflammation, we measured the serum levels of sTNFR1, sTNFR2, 19 eotaxin, leptin, and adiponectin as well as the total number of blood leukocytes in air exposed, 20 wildtype (C57BL/6) mice fed a diet consisting of either 10 or 60% fat (Figure 6 ), which were 30 21 weeks of age and older. DIO significantly increased the serum levels of sTNFR2 and leptin. 22
However, the levels of sTNFR1 and eotaxin as well as the total number of blood leukocytes wereunaffected by DIO. In addition, DIO had no effect upon the levels of the anti-inflammatory 1 hormone, adiponectin. 2
These results indicate that diet-induced obesity leads to the development of innate AHR 3 ( Figure 1B) , and to enhanced O 3 -induced lung permeability and inflammation (Figures 4 and 5) . 4
These data are consistent with our previous observations in genetically obese ob/ob (30; 48; 54) , 5 db/db (30; 37), and Cpe fat mice (29). However, our data indicate that C57BL/6 mice must 6 consume a high fat diet and remain obese for an extended period of time before the pulmonary 7 phenotype characteristic of obese mice is observed. 8
In this study, C57BL/6 mice fed a diet consisting of 60% fat from weaning until at least 9 20 weeks of age weighed nearly 40% more than age-and gender-matched mice fed a 10% fat 10 diet for the same time period. The increase in body mass observed in C57BL/6 mice fed a high 11 fat diet was more modest and less rapid than those exhibited by genetically obese ob/ob, db/db, 12
and Cpe fat mice (29; 30; 37; 54). The time period required for DIO to develop and the magnitude 13 of the increase in body mass we observed in C57BL/6 mice with DIO is consistent with other 14 studies (4; 24; 69). Similar to genetically obese mice, the increase in the total body mass of 15 C57BL/6 mice with DIO is almost entirely due to an increase in fat mass (4; 5). Furthermore, 16 C57BL/6 mice with DIO manifest several obesity-related pathologies, including hyperglycemia, 17 hyperinsulinemia, hyperleptinemia, insulin and leptin resistance, elevated plasma cholesterol, 18 and non-alcoholic steatohepatitis (23; 24; 34; 35; 43; 52; 58) . Of these obesity-related 19 pathologies, we only examined the levels of serum leptin, and as expected, C57BL/6 mice with 20 DIO had increased levels of serum leptin ( Figure 6 ). 21
Mice with DIO, which were maintained on a 60% fat diet from weaning until at least 30 22 weeks of age, had increased airway responsiveness to methacholine compared to age-andgender-matched mice maintained on a 10% fat diet. Innate AHR to nonspecific 1 bronchoconstrictors is also a consistent feature of genetically obese mice (29; 30; 37; 48; 54) . 2
The locus of the innate AHR observed in mice with DIO was the airways, rather than the lung 3 parenchyma, since G and H, parameters reflecting the mechanics of the lung tissue, did not 4 change with methacholine administration (Figure 2 ). The airways are also the locus of the innate 5 AHR observed in ob/ob and Cpe fat mice (29; 48) as well as db/db mice (unpublished 6 observations). 7
Breathing at low lung volumes has been shown to enhance airway responsiveness to 8 methacholine in human subjects (11), and because of alterations in the chest wall, functional 9 residual capacity is reduced in obese compared to lean human subjects (70; 71). Obese subjects 10 also breathe with lower V T than lean subjects (49) and changes in V T can also affect airway 11 responsiveness (11). However, it is unlikely that differences in either absolute or tidal lung 12 volumes can explain the innate AHR observed in mice with DIO: we removed the impact of the 13 chest wall by opening the chest wall and applying a fixed PEEP, and all mice were artificially 14 ventilated with the same V T . Although obesity can also reduce absolute lung size in mice (37), 15 the observation that lung PV curves were not affected by DIO (Figure 3 ), suggests that lung size 16 was not affected by DIO. In contrast to the lack of effect of DIO on E ( Figure 3 and gender-matched wildtype controls, whereas we observed only an approximate 40% increase 20 in body weight in these mice with DIO (Table 1 ). Hence, it is possible that obesity does not 21 impact E until a more substantial amount of adipose tissue has accumulated. In support of this 22 notion, there is an inverse relationship between BMI and lung volumes in human subjects (71).
Interestingly, in mice 30 weeks of age and older, DIO did increase H (Table 1 ) even though it did 1 not significantly alter E (Figure 3 , Table1). There was also a small but significant increase in 2 R aw in these mice (Table 1) . If this airway narrowing was not uniformly distributed in the lung, 3 it would result in lung units with longer time constants (higher resistances) effectively dropping 4 out during oscillation at high frequencies, an event that would increase H even though the "true" 5 elastic properties of the lung tissue were not altered. 6
As previously discussed, it is possible that the innate AHR observed in mice with DIO 7 may be related to chronic, low-grade systemic inflammation. In obese humans, there are 8 increased serum concentrations of cytokines, cytokine receptors, chemokines, and acute phase 9
proteins that correlate with the presence of diseases common to obesity, including type II 10 diabetes and atherosclerosis (1; 45; 61; 67). Our results ( Figure 6 ) also indicate increased serum 11 concentrations of leptin and sTNFR2 in mice fed a diet consisting of 60 versus 10% fat. 12
Similarly, increases in some markers of inflammation are observed in the serum of other types of 13 obese mice (29; 30; 37). Increased serum leptin cannot explain the development of innate AHR 14 in all types of obese mice. For example, ob/ob mice exhibit innate AHR, but are leptin deficient 15 (30; 48; 54). However, it is still conceivable that leptin may be important for AHR in mice with 16 DIO. Exogenous leptin has been shown to augment the AHR induced by allergen challenge in 17 mice (55). In addition, leptin has the capacity to either induce or augment TNF-expression 18 (16; 36; 50). Exogenous TNF-can induce AHR (31; 62). Thus, the increased levels of leptin 19 may enhance TNF-expression and lead to the development of AHR. Indeed, preliminary data 20 from our laboratory demonstrate that neutralization of TNF-with an anti-TNF-antibody 21 attenuates the innate AHR of obese db/db and Cpe fat mice (32). On the other hand, mice with 22 approximately the same percent increase in body mass as the mice 30 weeks of age and older 1 with DIO and also had increases in serum leptin (102.4±9.4 versus 30.6±9.9 ng/ml in mice fed 2 60% versus 10% fat diets, p<0.001). Others have reported that the adipose tissue of even 16-3 week-old mice with DIO is infiltrated with macrophages and exhibits heightened expression of 4 pro-inflammatory cytokines and chemokines (69). Therefore, innate AHR does not coincide 5 temporally with the onset of chronic systemic inflammation. Thus, it appears that if the low-6 grade, systemic inflammation of obesity accounts in any way for the pulmonary phenotype of 7 DIO mice, it must be present for an extended period of time before this phenotype is manifest. 8
Consistent with other types of obese mice (29; 37; 54), mice with DIO exhibit enhanced 9 O 3 -induced lung permeability ( Figure 4A ), as well as enhanced O 3 -induced pulmonary 10 expression of IL-6, eotaxin, KC, MIP-2, and IP-10 ( Figure 5 ). Despite the increased BALF 11 levels of KC, MIP-2, and IP-10, chemokines known to be important for recruitment of 12 neutrophils following acute O 3 exposure (27; 39), there were no differences between the dietary 13 groups in the emigration of neutrophils to the airspaces ( Figure 4B ). Similarly, we observed no 14 difference in BALF neutrophils between wildtype and ob/ob mice following O 3 exposure, 15 whereas the O 3 -induced influx of neutrophils is increased in db/db and Cpe fat versus wildtype 16 mice (29; 37). We do not know what accounts for the inability of the increased BALF 17 chemokines to recruit more neutrophils in ob/ob mice and in these DIO mice, but it is possible 18 that there are alterations in neutrophil adhesion molecules or heightened levels of neutrophil 19 chemokines in the blood that impact neutrophil migration into the lungs and airways. 20
It is unlikely that differences in the inhaled dose of O 3 account for the enhanced effects of 21 O 3 on BALF protein, cytokines, and chemokines in mice with DIO. The inhaled dose of O 3 is 22 the product of O 3 concentration, exposure duration, and V . E (68), and we have previously reportedno difference in V . E in mice with DIO (53). It is possible that the augmented effects of O 3 on 1 cytokine and chemokine expression in mice with DIO are the result of differences in lipids in the 2 epithelial cell membranes or in the lung surface liquid, leading to greater or altered lipid 3 peroxidation, the initial step in the inflammatory cascade brought about by O 3 (47). 4
As was the case for AHR, the augmented responses to O 3 were observed in mice with 5 DIO that were studied at 30 weeks of age and older, but not in mice studied at 20-22 weeks of 6 age, even though both groups of mice had approximately the same increase in body mass. These 7 data suggest that in this model, augmented responses to O 3 are not dependent upon the amount of 8 weight gained, but rather, on the amount of time that the animal remains obese. From our data, 9
we cannot determine the reason why the length of time obesity persists is important for the 10 development of innate AHR or augmented responses to O 3 . 11
Although mice with DIO manifest many aspects of the pulmonary phenotype 12 characteristic of genetically obese mice, this model was not ideal. First, this model does not 13 allow us to separate the effects of an increased intake of lipids versus an increased body mass on 14 the observed responses in mice with DIO. However, our observations in mice with DIO are 15 qualitatively similar to genetically obese mice, which were fed a diet with a much lower fat 16 content than 60%, suggesting that the obesity rather than the high lipid content of the diet 17 contributed to the observed responses. Second, because of the extended period of time required 18 to induce pulmonary changes in this model, and the sedentary life of these mice, even the 10% 19 fat fed mice were quite heavy. These mice weighed as much as 15 g more than the much 20 younger C57BL/6 controls used in our previous studies of genetically obese mice (29; 37). In 21 addition, in these 10% fat fed mice, serum leptin, a marker of adiposity, averaged nearly 25 22 ng/ml ( Figure 6D ), compared to 5-10 ng/ml in our previous studies of younger C57BL/6mice(29; 37). Essentially, while we were able to observe differences between the 60 and 10% fat 1 fed mice, it is possible that these actually represent differences between obesity (60% fat) and 2 overweight (10% fat). This may explain why we were unable to observe differences in serum 3 adiponectin ( Figure 6 ). The DIO model appears to be quite suitable for studying the metabolic 4 effects of obesity (58; 59; 66; 69), but the pulmonary phenotype may be less sensitive and 5 require either more substantial obesity (such as we observe in genetically obese mice), or less 6 marked obesity but of longer duration. Nevertheless, the value of this model is that it permits the 7 generation of obesity in mice with other genetic deficiencies that may be useful for 8 understanding the mechanistic basis for the relationship between obesity and asthma. 9
In conclusion, we report that mice with DIO exhibit innate AHR and enhanced O 3 -10 induced lung permeability and inflammation compared to 10% fat fed controls. These effects 11 appear to be dependent upon the consumption of a high fat diet for an extended period of time 12
and/or obesity of fairly long duration. Taken together with our results from genetically obese 13 mice, these data suggest that innate AHR and enhanced O 3 -induced pulmonary responses are 14 consistent features of obese mice and not dependent upon the modality of obesity induction.
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The authors would like to thank Dr. James P. Butler for discussions on the impact of 3 obesity on pulmonary mechanics. (BALF) of C57BL/6 mice fed a diet consisting of either 10 or 60% fat from weaning until at 7 least 30 weeks of age. BALF was collected 4 h following the cessation of a 3 h exposure to 8 either room air or 2 ppm ozone (O 3 ). n = 7 mice for each group. *p<0.05 compared to diet-9 matched, air-exposed controls. #p<0.05 compared 10% fat fed mice in the same exposure group. 10 Figure 6 . Serum concentrations of (A) soluble tumor necrosis factor receptor 1 (sTNFR1), (B) 12 sTNFR2, (C) eotaxin, (D) leptin, and (E) adiponectin as well as (F) the total number of blood 13 leukocytes from wildtype (C57BL/6) mice fed a diet consisting of either 10 or 60% fat in 14 the form of lard. Blood was collected and serum isolated from C57BL/6 mice reared from 15 weaning on a diet consisting of either 10 or 60% fat in the form of lard until at least 30 weeks of 16 age. Only serum from mice exposed to room air was analyzed. n = 5-13 mice for each group. 17 *p<0.05 compared to 10% fat fed mice. Results are mean±SEM. Measurements were made following the cessation of exposure to room air. R L , 6 total pulmonary resistance; R aw , airway resistance; G, coefficient of lung tissue damping; H, coefficient of lung tissue elastance; E, 7
